Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP synthase F1 subunit beta pseudogene 1 (ATP5F1BP1) is a genomic sequence related to the gene encoding the beta subunit of mitochondrial ATP synthase, but it does not produce a functional protein product. It belongs to the category of pseudogenes, which often result from gene duplication or retrotransposition and accumulate mutations that disable their coding potential. The true ATP synthase F1 subunit beta (encoded by ATP5F1B) plays a central role in cellular energy metabolism by catalyzing the synthesis of ATP via oxidative phosphorylation in mitochondria. Pseudogenes like ATP5F1BP1 may sometimes be involved in regulatory interactions at the RNA level, but there is no evidence for any functional or disease-related role of this pseudogene in current scientific literature[5].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase F1 subunit beta pseudogene 1 (ATP5F1BP1).